Gene and cell therapy firm Oxford Biomedica plc said on Monday it had appointed French pharmaceutical industry veteran Roch Doliveux as its non-executive chairman, as it eyes a potentially major role in producing coronavirus vaccine.
from Reuters: Health News https://ift.tt/3eAXz1C
No comments:
Post a Comment